{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:02:59Z","timestamp":1775487779498,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel therapeutic options are urgently needed to improve global treatment of virus infections. Herbal products with confirmed clinical safety features are attractive starting material for the identification of new antiviral activities. Here we demonstrate that <jats:italic>Cistus incanus<\/jats:italic> (Ci) herbal products inhibit human immunodeficiency virus (HIV) infections <jats:italic>in vitro<\/jats:italic>. Ci extract inhibited clinical HIV-1 and HIV-2 isolates, and, importantly, a virus isolate with multiple drug resistances, confirming broad anti-HIV activity. Antiviral activity was highly selective for virus particles, preventing primary attachment of the virus to the cell surface and viral envelope proteins from binding to heparin. Bioassay-guided fractionation indicated that Ci extract contains numerous antiviral compounds and therefore has favorably low propensity to induce virus resistance. Indeed, no resistant viruses emerged during 24 weeks of continuous propagation of the virus in the presence of Ci extracts. Finally, Ci extracts also inhibited infection by virus particles pseudotyped with Ebola and Marburg virus envelope proteins, indicating that antiviral activity of Ci extract extends to emerging viral pathogens. These results demonstrate that Ci extracts show potent and broad <jats:italic>in vitro<\/jats:italic> antiviral activity against viruses that cause life-threatening diseases in humans and are promising sources of agents that target virus particles.<\/jats:p>","DOI":"10.1038\/srep20394","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T11:33:25Z","timestamp":1454412805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins"],"prefix":"10.1038","volume":"6","author":[{"given":"Stephanie","family":"Rebensburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Koppensteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Brack-Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,2]]},"reference":[{"key":"BFsrep20394_CR1","unstructured":"WHO. The top 10 leading causes of death in the world 2000 and 2012. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/ (Accessed: 21st October 2015)."},{"key":"BFsrep20394_CR2","unstructured":"NEJM. Ebola Virus Disease: Current Knowledge. Available at: http:\/\/www.nejm.org\/action\/showMediaPlayer?doi=10.1056\/NEJMp1410741&aid=NEJMp1410741_attach_1 (Accessed: 21st October 2015)."},{"key":"BFsrep20394_CR3","unstructured":"AIDSinfo. FDA-Approved HIV Medicines. Available at: https:\/\/aidsinfo.nih.gov\/education-materials\/fact-sheets\/21\/58\/fda-approved-hiv-medicines (Accessed: 21st October 2015)."},{"key":"BFsrep20394_CR4","doi-asserted-by":"crossref","unstructured":"Taiwo, B., Hicks, C. & Eron, J. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1. Journal of Antimicrobial Chemotherapy (2010).","DOI":"10.1093\/jac\/dkq096"},{"key":"BFsrep20394_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/QAD.0b013e32835521a3","volume":"26","author":"S Vella","year":"2012","unstructured":"Vella, S., Schwartl\u00e4nder, B., Sow, S. P., Eholie, S. P. & Murphy, R. L. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. Aids 26, 1231\u20131241 (2012).","journal-title":"Aids"},{"key":"BFsrep20394_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/11597770-000000000-00000","volume":"26","author":"IL Tan","year":"2012","unstructured":"Tan, I. L. & McArthur, J. C. HIV-Associated neurological disorders. CNS drugs 26, 123\u2013134 (2012).","journal-title":"CNS drugs"},{"key":"BFsrep20394_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","volume":"72","author":"MW Tang","year":"2012","unstructured":"Tang, M. W. & Shafer, R. W. HIV-1 Antiretroviral Resistance. Drugs 72, e1\u2013e25 (2012).","journal-title":"Drugs"},{"key":"BFsrep20394_CR8","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"GM Cragg","year":"2013","unstructured":"Cragg, G. M. & Newman, D. J. Natural products: a continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA)-General Subjects 1830, 3670\u20133695 (2013).","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"BFsrep20394_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CMR.12.4.564","volume":"12","author":"MM Cowan","year":"1999","unstructured":"Cowan, M. M. Plant products as antimicrobial agents. Clinical microbiology reviews 12, 564\u2013582 (1999).","journal-title":"Clinical microbiology reviews"},{"key":"BFsrep20394_CR10","first-page":"965","volume":"63","author":"NR Farnsworth","year":"1985","unstructured":"Farnsworth, N. R., Akerele, O., Bingel, A. S., Soejarto, D. D. & Guo, Z. Medicinal plants in therapy. Bulletin of the world health organization 63, 965 (1985).","journal-title":"Bulletin of the world health organization"},{"key":"BFsrep20394_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","volume":"146","author":"LH Miller","year":"2011","unstructured":"Miller, L. H. & Su, X. Artemisinin: discovery from the Chinese herbal garden. Cell 146, 855\u2013858 (2011).","journal-title":"Cell"},{"key":"BFsrep20394_CR12","unstructured":"Nobelprize. Press Release for the 2015 Nobel Prize in Medicine Laureates. Available at: http:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/2015\/press.html (Accessed: 21st October 2015)."},{"key":"BFsrep20394_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virusres.2007.09.008","volume":"131","author":"M Mukhtar","year":"2008","unstructured":"Mukhtar, M. et al. Antiviral potentials of medicinal plants. Virus research 131, 111\u2013120 (2008).","journal-title":"Virus research"},{"key":"BFsrep20394_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/np200803m","volume":"75","author":"GA Cordell","year":"2012","unstructured":"Cordell, G. A. & Colvard, M. D. Natural products and traditional medicine: turning on a paradigm. Journal of natural products 75, 514\u2013525 (2012).","journal-title":"Journal of natural products"},{"key":"BFsrep20394_CR15","doi-asserted-by":"publisher","first-page":"e87487","DOI":"10.1371\/journal.pone.0087487","volume":"9","author":"M Helfer","year":"2014","unstructured":"Helfer, M. et al. The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLoS ONE 9(1), e87487 (2014).","journal-title":"PLoS ONE"},{"key":"BFsrep20394_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-2006-959403","volume":"60","author":"I Chinou","year":"1994","unstructured":"Chinou, I., Demetzos, C., Harvala, C., Roussakis, C. & Verbist, J. Cytotoxic and antibacterial labdane-type diterpenes from the aerial parts of Cistus incanus subsp. creticus. Planta medica 60, 34\u201336 (1994).","journal-title":"Planta medica"},{"key":"BFsrep20394_CR17","first-page":"731","volume":"54","author":"H Bouamama","year":"1998","unstructured":"Bouamama, H., Villard, J., Benharref, A. & Jana, M. Antibacterial and antifungal activities of Cistus incanus and C. monspeliensis leaf extracts. Therapie 54, 731\u2013733 (1998).","journal-title":"Therapie"},{"key":"BFsrep20394_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.foodres.2012.09.020","volume":"53","author":"P Riehle","year":"2013","unstructured":"Riehle, P., Vollmer, M. & Rohn, S. Phenolic compounds in Cistus incanus herbal infusions\u2014antioxidant capacity and thermal stability during the brewing process. Food Research International 53, 891\u2013899 (2013).","journal-title":"Food Research International"},{"key":"BFsrep20394_CR19","doi-asserted-by":"crossref","unstructured":"Wittpahl, G. et al. The polyphenolic composition of Cistus incanus herbal tea and its antibacterial and anti-adherent activity against Streptococcus mutans. Planta medica (2015).","DOI":"10.1055\/s-0035-1557822"},{"key":"BFsrep20394_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/0031-9422(91)85291-7","volume":"30","author":"F Petereit","year":"1991","unstructured":"Petereit, F., Kolodziej, H. & Nahrstedt, A. Flavan-3-ols and proanthocyanidins from Cistus incanus. Phytochemistry 30, 981\u2013985 (1991).","journal-title":"Phytochemistry"},{"key":"BFsrep20394_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2007.04.001","volume":"76","author":"K Droebner","year":"2007","unstructured":"Droebner, K., Ehrhardt, C., Poetter, A., Ludwig, S. & Planz, O. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral research 76, 1\u201310 (2007).","journal-title":"Antiviral research"},{"key":"BFsrep20394_CR22","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1021\/jf504119s","volume":"62","author":"P Riehle","year":"2014","unstructured":"Riehle, P., Rusche, N., Saake, B. & Rohn, S. Influence of the leaf content and herbal particle size on the presence and extractability of quantitated phenolic compounds in Cistus incanus herbal teas. Journal of agricultural and food chemistry 62, 10978\u201310988 (2014).","journal-title":"Journal of agricultural and food chemistry"},{"key":"BFsrep20394_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/pca.1281","volume":"22","author":"E Barraj\u00f3n\u2010Catal\u00e1n","year":"2011","unstructured":"Barraj\u00f3n\u2010Catal\u00e1n, E. et al. A systematic study of the polyphenolic composition of aqueous extracts deriving from several Cistus genus species: evolutionary relationship. Phytochemical Analysis 22, 303\u2013312 (2011).","journal-title":"Phytochemical Analysis"},{"key":"BFsrep20394_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.copbio.2011.08.007","volume":"23","author":"M Daglia","year":"2012","unstructured":"Daglia, M. Polyphenols as antimicrobial agents. Current opinion in biotechnology 23, 174\u2013181 (2012).","journal-title":"Current opinion in biotechnology"},{"key":"BFsrep20394_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/13892002113149990095","volume":"14","author":"K Andrae-Marobela","year":"2013","unstructured":"Andrae-Marobela, K., Ghislain, F. W., Okatch, H. & Majinda, R. R. Polyphenols: a diverse class of multi-target anti-HIV-1 agents. Current drug metabolism 14, 392\u2013413 (2013).","journal-title":"Current drug metabolism"},{"key":"BFsrep20394_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2007.05.002","volume":"76","author":"C Ehrhardt","year":"2007","unstructured":"Ehrhardt, C. et al. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral research 76, 38\u201347 (2007).","journal-title":"Antiviral research"},{"key":"BFsrep20394_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ptr.2876","volume":"24","author":"U Kalus","year":"2010","unstructured":"Kalus, U., Kiesewetter, H. & Radtke, H. Effect of CYSTUS052\u00ae and green tea on subjective symptoms in patients with infection of the upper respiratory tract. Phytotherapy research 24, 96\u2013100 (2010).","journal-title":"Phytotherapy research"},{"key":"BFsrep20394_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.antiviral.2009.10.001","volume":"84","author":"U Kalus","year":"2009","unstructured":"Kalus, U. et al. Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract: a prospective, randomised, placebo-controlled clinical study. Antiviral research 84, 267\u2013271 (2009).","journal-title":"Antiviral research"},{"key":"BFsrep20394_CR29","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1128\/AAC.00515-10","volume":"54","author":"S Kremb","year":"2010","unstructured":"Kremb, S. et al. EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors. Antimicrobial agents and chemotherapy 54, 5257\u20135268 (2010).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep20394_CR30","unstructured":"HIV-GRADE. HIV Sequence analysis for Research. Available at: http:\/\/www.hiv-grade.de\/grade\/deployed\/rade.pl?program=hivalg (Accessed: 21st October 2015)."},{"key":"BFsrep20394_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nprot.2011.330","volume":"6","author":"D Daelemans","year":"2011","unstructured":"Daelemans, D., Pauwels, R., De Clercq, E. & Pannecouque, C. A time-of-drug addition approach to target identification of antiviral compounds. Nature protocols 6, 925\u2013933 (2011).","journal-title":"Nature protocols"},{"key":"BFsrep20394_CR32","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1128\/JVI.05915-11","volume":"86","author":"H Koppensteiner","year":"2012","unstructured":"Koppensteiner, H., Banning, C., Schneider, C., Hohenberg, H. & Schindler, M. Macrophage internal HIV-1 is protected from neutralizing antibodies. Journal of virology 86, 2826\u20132836 (2012).","journal-title":"Journal of virology"},{"key":"BFsrep20394_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fimmu.2013.00385","volume":"4","author":"BJ Connell","year":"2013","unstructured":"Connell, B. J. & Lortat-Jacob, H. Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition. Frontiers in immunology 4(385), 2 (2013).","journal-title":"Frontiers in immunology"},{"key":"BFsrep20394_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<167::AID-RMV199>3.0.CO;2-K","volume":"7","author":"DE Ott","year":"1997","unstructured":"Ott, D. E. Cellular proteins in HIV virions. Reviews in medical virology 7, 167\u2013180 (1997).","journal-title":"Reviews in medical virology"},{"key":"BFsrep20394_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/1087057113497095","volume":"19","author":"S Helleboid","year":"2013","unstructured":"Helleboid, S. et al. The identification of naturally occurring neoruscogenin as a bioavailable, potent and high-affinity agonist of the nuclear receptor ROR\u03b1 (NR1F1). Journal of biomolecular screening 19(3), 399\u2013406 (2013).","journal-title":"Journal of biomolecular screening"},{"key":"BFsrep20394_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/infdis\/jir378","volume":"204","author":"A K\u00fchl","year":"2011","unstructured":"K\u00fchl, A. et al. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin. Journal of Infectious Diseases 204, 850\u2013860 (2011).","journal-title":"Journal of Infectious Diseases"},{"key":"BFsrep20394_CR37","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/v6041654","volume":"6","author":"K Gnir\u00df","year":"2014","unstructured":"Gnir\u00df, K. et al. Analysis of determinants in filovirus glycoproteins required for tetherin antagonism. Viruses 6, 1654\u20131671 (2014).","journal-title":"Viruses"},{"key":"BFsrep20394_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1387-2656(08)00012-4","volume":"14","author":"D Chattopadhyay","year":"2008","unstructured":"Chattopadhyay, D. & Khan, M. T. H. Ethnomedicines and ethnomedicinal phytophores against herpesviruses. Biotechnology annual review 14, 297\u2013348 (2008).","journal-title":"Biotechnology annual review"},{"key":"BFsrep20394_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11418-013-0767-y","volume":"67","author":"SLA Kadir","year":"2013","unstructured":"Kadir, S. L. A., Yaakob, H. & Zulkifli, R. M. Potential anti-dengue medicinal plants: a review. Journal of natural medicines 67, 677\u2013689 (2013).","journal-title":"Journal of natural medicines"},{"key":"BFsrep20394_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jvh.12112","volume":"20","author":"Y Chen","year":"2013","unstructured":"Chen, Y. & Zhu, J. Anti\u2010HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review. Journal of viral hepatitis 20, 445\u2013452 (2013).","journal-title":"Journal of viral hepatitis"},{"key":"BFsrep20394_CR41","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.3748\/wjg.v20.i11.2941","volume":"20","author":"UA Ashfaq","year":"2014","unstructured":"Ashfaq, U. A. & Idrees, S. Medicinal plants against hepatitis C virus. World journal of gastroenterology: WJG 20, 2941\u20132947 (2014).","journal-title":"World journal of gastroenterology: WJG"},{"key":"BFsrep20394_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ptr.5433","volume":"29","author":"W Chingwaru","year":"2015","unstructured":"Chingwaru, W., Vidmar, J. & Kapewangolo, P. T. The potential of sub\u2010saharan african plants in the management of human immunodeficiency virus infections: A review. Phytotherapy Research 29, 1452\u20131487 (2015).","journal-title":"Phytotherapy Research"},{"key":"BFsrep20394_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/19390210802519648","volume":"5","author":"L Dvorkin-Camiel","year":"2008","unstructured":"Dvorkin-Camiel, L. & Whelan, J. S. Tropical american plants in the treatment of infectious diseases. Journal of dietary supplements 5, 349\u2013372 (2008).","journal-title":"Journal of dietary supplements"},{"key":"BFsrep20394_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1055\/s-0030-1270731","volume":"77","author":"GA Cordell","year":"2011","unstructured":"Cordell, G. A. Sustainable medicines and global health care. Planta medica 77, 1129\u20131138 (2011).","journal-title":"Planta medica"},{"key":"BFsrep20394_CR45","doi-asserted-by":"crossref","unstructured":"Li, G. et al. An integrated map of HIV genome-wide variation from a population perspective. Retrovirology 12 (2015).","DOI":"10.1186\/s12977-015-0148-6"},{"key":"BFsrep20394_CR46","doi-asserted-by":"crossref","unstructured":"Peterson, K., Jallow, S., Rowland-Jones, S. L. & de Silva, T. I. Antiretroviral therapy for HIV-2 infection: recommendations for management in low-resource settings. AIDS research and treatment 2011 (2011).","DOI":"10.1155\/2011\/463704"},{"key":"BFsrep20394_CR47","first-page":"147","volume":"17","author":"S Bush","year":"2014","unstructured":"Bush, S. & Tebit, D. HIV-1 group O origin, evolution, pathogenesis and treatment: Unraveling the complexity of an outlier 25 years later. AIDS reviews 17, 147\u2013158 (2014).","journal-title":"AIDS reviews"},{"key":"BFsrep20394_CR48","doi-asserted-by":"crossref","unstructured":"Megens, S. & Laethem, K. V. HIV-1 genetic variation and drug resistance development. Expert Review of Anti-infective Therapy 11 (2013).","DOI":"10.1586\/14787210.2013.844649"},{"key":"BFsrep20394_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/QAI.0000000000000698","volume":"70","author":"A Depatureaux","year":"2015","unstructured":"Depatureaux, A. et al. HIV-1 group O resistance against integrase inhibitors. Journal of acquired immune deficiency syndromes 70, 9\u201315 (2015).","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"BFsrep20394_CR50","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1073\/pnas.0909587107","volume":"107","author":"MC Wolf","year":"2010","unstructured":"Wolf, M. C. et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences 107, 3157\u20133162 (2010).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep20394_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.antiviral.2013.03.017","volume":"98","author":"AA Haqqani","year":"2013","unstructured":"Haqqani, A. A. & Tilton, J. C. Entry inhibitors and their use in the treatment of HIV-1 infection. Antiviral research 98, 158\u2013170 (2013).","journal-title":"Antiviral research"},{"key":"BFsrep20394_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1021\/id500025n","volume":"1","author":"EK Nyakatura","year":"2014","unstructured":"Nyakatura, E. K., Frei, J. C. & Lai, J. R. Chemical and structural aspects of Ebola Virus entry inhibitors. ACS infectious diseases 1, 42\u201352 (2014).","journal-title":"ACS infectious diseases"},{"key":"BFsrep20394_CR53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0300-9084(01)01290-1","volume":"83","author":"D Spillmann","year":"2001","unstructured":"Spillmann, D. Heparan sulfate: anchor for viral intruders? Biochimie 83, 811\u2013817 (2001).","journal-title":"Biochimie"},{"key":"BFsrep20394_CR54","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1128\/JVI.01621-12","volume":"87","author":"B Salvador","year":"2013","unstructured":"Salvador, B. et al. Filoviruses utilize glycosaminoglycans for their attachment to target cells. Journal of virology 87, 3295\u20133304 (2013).","journal-title":"Journal of virology"},{"key":"BFsrep20394_CR55","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/hep.21896","volume":"46","author":"A Schulze","year":"2007","unstructured":"Schulze, A., Gripon, P. & Urban, S. Hepatitis B virus infection initiates with a large surface protein\u2013dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759\u20131768 (2007).","journal-title":"Hepatology"},{"key":"BFsrep20394_CR56","doi-asserted-by":"publisher","first-page":"41003","DOI":"10.1074\/jbc.M302267200","volume":"278","author":"H Barth","year":"2003","unstructured":"Barth, H. et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. Journal of Biological Chemistry 278, 41003\u201341012 (2003).","journal-title":"Journal of Biological Chemistry"},{"key":"BFsrep20394_CR57","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1128\/JVI.00896-14","volume":"88","author":"CC Colpitts","year":"2014","unstructured":"Colpitts, C. C. & Schang, L. M. A small molecule inhibits virion attachment to heparan sulfate-or sialic acid-containing glycans. Journal of virology 88, 7806\u20137817 (2014).","journal-title":"Journal of virology"},{"key":"BFsrep20394_CR58","doi-asserted-by":"crossref","unstructured":"Wilen, C. B., Tilton, J. C. & Doms, R. W. Molecular mechanisms of HIV entry in Viral Molecular Machines 223\u2013242 (Springer, 2012).","DOI":"10.1007\/978-1-4614-0980-9_10"},{"key":"BFsrep20394_CR59","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/j.pain.0000000000000177","volume":"156","author":"S Yuan","year":"2015","unstructured":"Yuan, S. et al. A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain. Pain 156, 1311\u20131319 (2015).","journal-title":"Pain"},{"key":"BFsrep20394_CR60","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1128\/AAC.00494-09","volume":"53","author":"L Alexander","year":"2009","unstructured":"Alexander, L. et al. Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors. Antimicrobial agents and chemotherapy 53, 4726\u20134732 (2009).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep20394_CR61","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11481-006-9011-9","volume":"1","author":"M Kaul","year":"2006","unstructured":"Kaul, M. & Lipton, S. A. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. Journal of Neuroimmune Pharmacology 1, 138\u2013151 (2006).","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"BFsrep20394_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12640-011-9279-2","volume":"21","author":"I Mocchetti","year":"2012","unstructured":"Mocchetti, I., Bachis, A. & Avdoshina, V. Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. Neurotoxicity research 21, 79\u201389 (2012).","journal-title":"Neurotoxicity research"},{"key":"BFsrep20394_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jac\/dkt412","volume":"69","author":"N Zhou","year":"2014","unstructured":"Zhou, N. et al. Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068. Journal of Antimicrobial Chemotherapy 69, 573\u2013581 (2014).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BFsrep20394_CR64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-med-050911-163701","volume":"64","author":"J Baeten","year":"2013","unstructured":"Baeten, J. & Celum, C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annual review of medicine 64, 219\u2013232 (2013).","journal-title":"Annual review of medicine"},{"key":"BFsrep20394_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery 14, 111\u2013129 (2015).","journal-title":"Nature Reviews Drug Discovery"},{"key":"BFsrep20394_CR66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of natural products 75, 311\u2013335 (2012).","journal-title":"Journal of natural products"},{"key":"BFsrep20394_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1039\/C4NP00085D","volume":"32","author":"J Martinez","year":"2015","unstructured":"Martinez, J., Sasse, F., Br\u00f6nstrup, M., Diez, J. & Meyerhans, A. Antiviral drug discovery: broad-spectrum drugs from nature. Natural product reports 32, 29\u201348 (2015).","journal-title":"Natural product reports"},{"key":"BFsrep20394_CR68","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0042-6822(91)90537-L","volume":"185","author":"K Peden","year":"1991","unstructured":"Peden, K., Emerman, M. & Montagnier, L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1 LAI, HIV-1 MAL and HIV-1 ELI. Virology 185, 661\u2013672 (1991).","journal-title":"Virology"},{"key":"BFsrep20394_CR69","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1128\/jvi.69.6.3949-3954.1995","volume":"69","author":"EO Freed","year":"1995","unstructured":"Freed, E. O., Englund, G. & Martin, M. A. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. Journal of virology 69, 3949\u20133954 (1995).","journal-title":"Journal of virology"},{"key":"BFsrep20394_CR70","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/jvi.68.3.1581-1585.1994","volume":"68","author":"LG G\u00fcrtler","year":"1994","unstructured":"G\u00fcrtler, L. G. et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. Journal of virology 68, 1581\u20131585 (1994).","journal-title":"Journal of virology"},{"key":"BFsrep20394_CR71","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1083\/jcb.201201144","volume":"199","author":"R Gaudin","year":"2012","unstructured":"Gaudin, R. et al. Critical role for the kinesin KIF3A in the HIV life cycle in primary human macrophages. The Journal of cell biology 199, 467\u2013479 (2012).","journal-title":"The Journal of cell biology"},{"key":"BFsrep20394_CR72","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1099\/0022-1317-79-4-731","volume":"79","author":"M Wachinger","year":"1998","unstructured":"Wachinger, M. et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. Journal of General Virology 79, 731\u2013740 (1998).","journal-title":"Journal of General Virology"},{"key":"BFsrep20394_CR73","doi-asserted-by":"crossref","unstructured":"Fuss, I. J., Kanof, M. E., Smith, P. D. & Zola, H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Current protocols in immunology. 7.1.1\u20137.1.8 (2009).","DOI":"10.1002\/0471142735.im0701s85"},{"key":"BFsrep20394_CR74","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"BFsrep20394_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods 65, 55\u201363 (1983).","journal-title":"Journal of immunological methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:03:41Z","timestamp":1672887821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,22]]}},"alternative-id":["BFsrep20394"],"URL":"https:\/\/doi.org\/10.1038\/srep20394","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]},"assertion":[{"value":"10 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20394"}}